Genome Therapeutics Corp, Schering-Plough deal

The partners will discover and develop treatments for fungal diseases. Using its bioinformatics and functional genomics capabilities,

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE